Product information and disease description Product description Product information

Effect of BIM-IOL System on quality measures

5 evidence topics · 5 sources

MIPS Quality ID 141: POAG reduction of IOP by 20% or plan of care

“Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 20% from the pre-intervention level) OR if the most recent IOP was not reduced by at least 20% from the pre-intervention level, a plan of care was documented within the 12 month performance period.” (opens the source at this quote in a new tab)

Proportion of eyes with IOP reduction of more than 20%: first-in-human study

“All month 36 subjects maintained an IOP reduction > 20% and all but two subjects (90.5%, n = 19) achieved an IOP < 18 mmHg.” (opens the source at this quote in a new tab)

MIPS Quality ID 191: visual acuity after cataract surgery, with glaucoma exclusion

“Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery.” (opens the source at this quote in a new tab)

Table 1 - Significant Ocular Conditions	Quoted entry
Condition listed	“Glaucoma”

Visual acuity endpoint in the phase 3 trials

“The co-primary endpoints are (1) the time-matched mean IOP change from baseline at 8 and 10 a.m. at two and six weeks and three months and (2) BCDVA of 20/40 or better at 12 months.” (opens the source at this quote in a new tab)

MIPS Quality ID 389: refractive outcome after cataract surgery

“Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 1.0 diopters of their planned (target) refraction.” (opens the source at this quote in a new tab)

HEDIS measures for glaucoma and BIM-IOL System-specific effect on quality measures

No evidence found.